InnoVet-AMR is aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security.
The initiative responds to a need identified by the international scientific and development communities. It is supported with high-level policy processes, including the UN political declaration on AMR (2016), G7/20, Global Health Security Agenda and Action Plan, as well as Global Action Plans of the World Health Assembly and the World Organization for Animal Health.
Antimicrobial resistance (AMR) in animals remains a growing problem that threatens our ability to effectively treat bacterial infections in humans and animals.
Livestock and aquaculture keepers in low- and middle-income countries (LMICs) are highly affected by the increase of infectious disease outbreaks and loss in livestock productivity, which ultimately endangers food security and disrupts international trades. At the same time, the contamination of animal products, and the wider environment, with antimicrobial-resistant bacteria is a risk factor for humans, animals, and the environment.
In 2016, the UN General Assembly recognized AMR as a global threat that disproportionally affects people in LMICs. The international community was called upon to rise to the complex challenge of AMR and take urgent action.
InnoVet-AMR will fund research to develop new animal vaccines and other innovations to fight AMR in livestock and aquaculture production, particularly in lLMICs.
The initiative builds on DHSC’s expertise championing innovation by supporting research and technology to improve lives. It also draws on IDRC’s history as a development research funder with decades of experience building knowledge-focused cross-sector partnerships.
Through InnoVet-AMR, IDRC and DHSC aim to achieve two key objectives:
- Support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs.
- Build effective partnerships to better coordinate discovery, development, and sustainable delivery of innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs.
A key element of the InnoVet-AMR partnership will be the associated funding opportunity, to be launched over the coming months. More information will be released closer to the funding call announcement.